Carvedilol for Prevention of Restenosis After Directional Coronary Atherectomy - EUROCARE

Description:

The goal of this study was to assess the safety and efficacy of carvedilol in the prevention of coronary restenosis among patients with coronary artery disease (CAD) undergoing directional coronary atherectomy (DCA).